Navigation Links
NABP PMP InterConnect Development Complete; PMPs Continue to Sign on to Participate in National System for Tracking Drug Abuse and Diversion
Date:6/6/2011

MOUNT PROSPECT, Ill., June 6, 2011 /PRNewswire-USNewswire/ -- As part of its continuing efforts to protect public health by reducing abuse, misuse, and diversion of prescription medications, the National Association of Boards of Pharmacy® (NABP®) has completed development of the NABP PMP InterConnect. NABP will now focus on working with participating state prescription monitoring program (PMP) administrators and their software vendors to finalize the software interface, so that PMP systems can efficiently and effectively communicate with the NABP InterConnect and facilitate interoperability among PMPs. Data sharing among states is an important part of early detection of prescription drug abuse and doctor shopping, to allow appropriate intervention and prevention of substance abuse and possible diversion of controlled substances.

Many state PMP administrators have already begun to use the NABP InterConnect by setting up their PMPs' access rules and populating the "rules engine" on the NABP InterConnect. The rules engine is the tool that gives states complete autonomy and control over how the NABP InterConnect will manage information requests to and from other participating states in the program.

Used only to facilitate the communications process, the NABP InterConnect will retain no prescription data and all PMP data will remain resident with the PMP. In addition, the interconnected communications hub will be housed in highly secure facilities, to maintain the confidentiality of this sensitive information.

To date, the PMPs in Connecticut, Indiana, Mississippi, North Dakota, Ohio, South Carolina, Virginia, and West Virginia have executed a Memorandum of Understanding (MOU) to participate in NABP InterConnect. Additionally, PMPs in Arizona, Kansas, Louisiana, Michigan, and Nevada intend to participate in NABP InterConnect and have MOUs in the final review stages. More than 12 other PMPs have also expressed their intent to participate in the program, but must first obtain clearer authority to share data across state lines, must procure software, complete development on their own PMP, or move the MOU further along in the review process. States that must enter into state-to-state MOUs by statute, regulation, or program policy, are still welcome to participate in NABP InterConnect.  

Utilizing NABP's existing financial resources, the Association will cover the annual participation fees for all participating states for at least five years, and it is the Association's goal that states will never have to pay annual participation fees to participate in NABP InterConnect. NABP will work to offset costs associated with amendments to existing PMP software, which are needed to interface with the NABP InterConnect. In addition, NABP will cover all costs associated with the development and ongoing operation of the program. The NABP Foundation will also make available unrestricted educational grants available for those states needing additional assistance in enhancing their PMPs for this purpose. Those interested in obtaining more information on NABP InterConnect, should contact NABP Government Affairs staff at governmentaffairs@nabp.net.

Other NABP health and safety programs include the VIPPS® (Verified Internet Pharmacy Practice Sites) accreditation program, the Not Recommended list of online drug distributors, and the AWARxE consumer protection program. Recently, NABP commissioned task forces to address patient health and safety issues including the Controlled Substances Act, PMP program standards, electronic prescribing, prescription labels, and medication collection programs.

NABP is the independent, international, and impartial Association that assists its member boards and jurisdictions in developing, implementing, and enforcing uniform standards for the purpose of protecting the public health.


'/>"/>
SOURCE National Association of Boards of Pharmacy
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Three States Sign on to Participate in NABPs Interconnected Prescription Monitoring System
2. Pharmacyclics Reports Recent Developments From Clinical Studies of its Btk Inhibitor PCI-32765
3. Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase
4. Novel First-in-Class Anti-Cancer Agent in Development by Niiki Pharma Shows Promising Phase I Results
5. Awarepoint Vice President - Government Business Development Chris Doran to Speak at VHA Real Time Location Systems Conference 2011
6. Pharmacy Technicians Assist Pharmacy Teams in Development of Drug Shortage Protocols
7. Reportlinker Adds Advances in Drug-Diagnostic Co-Development
8. Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
9. Radius, 3M Drug Delivery Systems Sign Development Agreement for Transdermal Delivery of BA058 for Treatment of Osteoporosis
10. Reportlinker Adds A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market
11. Omeros Announces Clinical Development Programs for OMS103HP and OMS302
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017  The Global Health Innovative Technology Fund ... to battle infectious diseases around the globe, today ... could help deliver a range of new innovative ... This latest round of targeted support ... testing a pediatric formulation of a drug considered ...
(Date:3/29/2017)... March 29, 2017 Optometrists have staunchly ... the highest standard in quality and care for ... its objective Wavefront-driven refraction technologies and process to ... enables an unprecedented level of refraction and correction ... relegated to Topgun Navy fighter pilots, but now ...
(Date:3/29/2017)... Research and Markets has announced the addition ... their offering. ... The global lifestyle drugs market to grow at a CAGR of ... Lifestyle Drugs Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... 30, 2017 , ... This morning, more than 275 medical ... support for an independent Vaccine Safety Commission. Five of the signers of the ... hold a press conference at 9:00 AM Friday, March 31 at the ...
(Date:3/29/2017)... ... ... ARI Network Services, Inc. (NASDAQ: ARIS) announced today that Rhino Ag has ... of more than 650 U.S.-based dealers. Rhino, a member of the Alamo Group, offers ... and cutters, rear blades, post hole diggers, pasture renovators, tillers, disc mowers and box ...
(Date:3/29/2017)... New York City, NY (PRWEB) , ... March ... ... governing body for men’s and women’s professional squash, announced it has enlisted New ... marketing partner. The agency will develop and procure sponsorship opportunities for the ...
(Date:3/29/2017)... ... ... main cause of hay fever in the United States, with an estimated 95 percent of ... July each year; with the worst time for sufferers being June and July. , ... provide an effective defense against grass pollen; they are proven in independent studies to trap ...
(Date:3/29/2017)... Amherst, Massachusetts (PRWEB) , ... March 30, 2017 , ... ... has had great success and feedback from high school and college students who have ... is being held July 7-23 and YFI is now accepting applications for enrollment. ...
Breaking Medicine News(10 mins):